Yaz Birth Control Lawsuit - Consumer Drug Report
Bayer settles Yaz® lawsuits

Bayer Healthcare currently faces about 11,300 Yaz lawsuits filed by women who claim that Yaz causes serious injuries. The pharmaceutical giant agreed to settle about 70 of these lawsuits.

In its 2011 Annual Financial Report, the company informed investors it has have settled a number of cases and may continue to settle case by case.

On December 8, 2011, a panel of advisors for the U.S. Food and Drug Administration met to discuss the benefits of birth contraceptives Yaz and Yasmin®. In a vote of 15 to 11, the agency determined that the benefits of the pills outweighed the risks.

A study conducted by Canada Health officials compared what are considered “new generation” birth control pills, which includes Yaz and Yasmin, to traditional birth control pills. Results of the study revealed that Yaz and Yasmin pose a higher risk for blood clots than traditional pills.

Yaz was introduced by Bayer in 2006. The oral contraceptive generated sales of $781 million for the company in 2009 but those sales have since dropped to $374 million due to emerging safety concerns.

Women who have taken Bayer’s oral contraceptives claim to have suffered adverse side effects such as stroke, pulmonary embolism, deep vein thrombosis, gallbladder disease, and even death.

Yaz, Yasmin, and other new generation birth control pills contain an active ingredient known as drospirenone which is not found in traditional birth control pills. The FDA conducted a study examining more than 800,000 women. The study compared pills containing drospirenone to pills not containing drospirenone. Results revealed that women on pills containing drospirenone face a 74% higher risk for developing blood clots than women taking traditional pills.

Prior to the settlement of Yaz lawsuits, mediation was ordered between all parties involved. Judge Hendon, who is presiding over all Yaz lawsuits, issued an order which indefinitely continued the start of the first trial. The order mandated both parties to engage in settlement negotiations in good faith.


About the Contributor

Related Posts